• Discover Astex
    • Our Mission & Values
    • Our Leadership Team
    • Our History
    • Corporate Social Responsibility
  • R&D
    • Clinical Pipeline
      • Proprietary Products and Programs
        • Tolinapant (ASTX660) Dual IAP Antagonist (T-cell Lymphomas)
        • Beroterkib (ASTX029) Extracellular Signal-Related Protein Kinases (ERK 1/2) Inhibitor (Solid Tumors)
        • ASTX295 Oral Murine Double Minute 2 (MDM2) antagonist (Solid Tumors)
      • Partnered Products and Programs
        • Kisqali® (ribociclib) CDK4/6 inhibitor (Oncology)
        • Balversa® (erdafitinib) FGFr inhibitor (Oncology)
        • Truqap™ PKB/Akt Inhibitor (Oncology)
        • Multiple Targets and Therapeutic Areas
    • Pyramid™ Discovery Platform
    • Oncology and CNS Discovery
    • Sustaining Innovation Postdocs
  • Partnering
  • Our People & Culture
    • Career Opportunities
  • Media
    • Press Releases
    • Conferences & Meetings
    • Presentations & Publications
    • Interactive Scientific Resources
      • Interactive Software
    • Astex in the News
  • Contact
  • Search
  • Menu Menu
You are here: Home1 / 20232 / 17th International Congress on Myelodysplastic Syndromes

17th International Congress on Myelodysplastic Syndromes

3 May 2023/in 2023, Events

The 17th International Congress on Myelodysplastic Syndromes

3 – 6 May 2023
Marseille, France
Visit the conference website

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 Renee Hansen https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg Renee Hansen2023-05-03 23:59:292023-01-05 00:54:0817th International Congress on Myelodysplastic Syndromes

© Astex Pharmaceuticals
All rights reserved

astex

Useful links

  • Home
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Legal
  • LinkedIn

Member of the Otsuka Group

2023 Int. Congress on MDS: Efficacy and Safety of Oral Decitabine/Cedazuridine...Wu et al., “A Diverse Array of Large Capsules Transform in Response to Stimuli”;...
Scroll to top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok